Healthcare Equipment and Supplies
Company Overview of IMRIS, Inc.
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovas...
100-1370 Sony Place
Winnipeg, MB R3T 1N5
Founded in 2005
Key Executives for IMRIS, Inc.
Chief Executive Officer, President, Director and Member of Strategic Committee
Total Annual Compensation: $450.0K
Principal Accounting Officer and Director of Finance
Total Annual Compensation: $160.0K
Executive Vice President of Operations
Total Annual Compensation: $250.0K
Chief Technology Officer and Executive Vice President of Research & Development
Total Annual Compensation: $285.0K
Compensation as of Fiscal Year 2014.
IMRIS, Inc. Key Developments
Nasdaq To File Form 25 To Delist Common Stock Of Imris
Jul 22 15
The Nasdaq Stock Market announced that it will delist the common stock of Imris Inc. Imris Inc’s stock was suspended on June 4, 2015 and has not traded on Nasdaq since that time. Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for the company. The delisting become effective ten days after the Form 25 is filed.
IMRIS, Inc.(NasdaqGS:IMRS) dropped from NASDAQ Composite Index
Jun 3 15
IMRIS, Inc. will be removed from Nasdaq Composite Index.
TSX Determines To Delist Common Shares Of IMRIS
Jun 3 15
Further to TSX Bulletin 2015-0549 dated May 26, 2015, TSX has determined to delist the common shares of IMRIS Inc. at the close of business on July 2, 2015 for failure to meet the continued listing requirements of TSX. The common shares will remain suspended from trading.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries